Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats

被引:68
作者
Karasu, C
Ozansoy, G
Bozkurt, O
Erdogan, D
Omeroglu, S
机构
[1] ANKARA UNIV,DEPT BIOCHEM,FAC PHARM,TR-06100 ANKARA,TURKEY
[2] GAZI UNIV,DEPT HISTOL & EMBRYOL,FAC MED,ANKARA,TURKEY
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1997年 / 46卷 / 08期
关键词
D O I
10.1016/S0026-0495(97)90072-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study, we evaluated the effects of vitamin E an the vascular reactivity and structure of thoracic aorta from streptozotocin (STZ)-diabetic rats. Plasma glucose, cholesterol, and triglyceride concentrations in rats were increased markedly by STZ-diabetes. The thiobarbituric acid (TBA) reactivity revel as an index of lipid peroxidation was higher in both plasma and aorta of STZ-diabetic rats compared with controls. The rings of thoracic aorta with or without endothelium were mounted in organ chambers for measurement of isometric tension and were contracted by a single dose (10(-5) mol/L) and then cumulative doses of noradrenaline ([NA] 10(-9) to 10(-5) mol/L). Pretreatment with methylene blue (MB) or removal of the endothelium resulted in a similar degree of enhancement in NA-induced contraction of control rings. STZ-diabetes increased the fast and slow components of NA-induced contraction in air experiments. The maximal contractile response of aorta to NA was also augmented by STZ-diabetes, whereas the sensitivity (pD(2)) remained unaltered. STZ-diabetes resulted in significant increases in the maximum contractile response and sensitivity of aorta to KCl. STZ-diabetic rats showed a significant reduction in the percentage of endothelial response (PER). A group of diabetic rats was treated from the time of diabetes induction with a 0.5% dietary supplement of vitamin E. Vitamin E supplementation of STZ-diabetic rats eliminated accumulation of lipid peroxides and returned plasma triglycerides toward normal levels. Diabetes-induced abnormal contractility and endothelial dysfunction were significantly but not completely prevented by vitamin E treatment. The endothelium-independent relaxation response to sodium nitroprusside (SNP) was not affected by diabetes or vitamin E treatment. Electron microscopic examination of thoracic aorta revealed that normal tissue organization was disrupted in STZ-diabetic rats, and that vitamin E treatment can protect the morphological integrity of aorta against STZ-diabetes. The results suggest the following: (1) The increased triglycerides/lipid peroxides may be an important reason for morphological or functional disruption of endothelium and enhanced activation of contractile mechanisms of vascular smooth muscle in STZ-diabetic rats. Both contribute to an increased responsiveness of diabetic aorta to vasoconstrictor agents. (2) Vitamin E treatment of STZ-diabetic rats can prevent the development of abnormal contractility and structure and endothelial dysfunction in aorta. (3) The triglyceride- and/or lipid peroxidation-lowering effect of vitamin E may be crucial for the protective effect of this vitamin on the vasculature. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:872 / 879
页数:8
相关论文
共 53 条
[1]   ENHANCED CONTRACTILE RESPONSES OF ARTERIES FROM DIABETIC RATS TO ALPHA-1-ADRENOCEPTOR STIMULATION IN THE ABSENCE AND PRESENCE OF EXTRACELLULAR CALCIUM [J].
ABEBE, W ;
HARRIS, KH ;
MACLEOD, KM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (02) :239-248
[2]   DIFFERENCES IN VASCULAR-RESPONSES TO VASOACTIVE AGENTS OF BASILAR ARTERY AND AORTA FROM RABBITS WITH ALLOXAN-INDUCED DIABETES [J].
ABIRU, T ;
KAMATA, K ;
MIYATA, N ;
KASUYA, Y .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1990, 68 (07) :882-888
[3]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[4]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[5]   ADVANCED GLYCOSYLATION PRODUCTS QUENCH NITRIC-OXIDE AND MEDIATE DEFECTIVE ENDOTHELIUM-DEPENDENT VASODILATATION IN EXPERIMENTAL DIABETES [J].
BUCALA, R ;
TRACEY, KJ ;
CERAMI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :432-438
[6]  
BURTON GW, 1982, LANCET, V2, P327
[7]  
CHANG KC, 1993, J PHARMACOL EXP THER, V266, P992
[8]   INHIBITION OF SMOOTH-MUSCLE CELL-PROLIFERATION AND PROTEIN-KINASE-C ACTIVITY BY TOCOPHEROLS AND TOCOTRIENOLS [J].
CHATELAIN, E ;
BOSCOBOINIK, DO ;
BARTOLI, GM ;
KAGAN, VE ;
GEY, FK ;
PACKER, L ;
AZZI, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1176 (1-2) :83-89
[9]  
CHISHOLM GM, 1992, DIABETES S2, V41, P66
[10]  
COHEN RA, 1993, CIRCULATION, V87, P67